Scholarlink

Purpose <p>The increasing prevalence of Metabolic Dysfunction-Associated Steatosis Liver Disease (MASLD) highlights the need for effective assessment tools, particularly for the quantitative evaluation of hepatic steatosis. Given the limited availability of transient elastography (TE), especially in resource-limited settings, we aimed to develop an Artificial Intelligence (AI) model to quantify hepatic steatosis using conventional ultrasound, which is widely available in most healthcare facilities.</p> Methods <p>Liver ultrasonographic images and Controlled Attenuation Parameter (CAP) scores obtained from TE were collected from patients between 2017 and 2023. A predictive model was developed by integrating YOLOv8 for image classification with Principal Component Analysis and Lasso regression to estimate CAP scores from the ultrasonographic images. The dataset was randomly divided into training (80%), validation (10%), and test (10%) sets. Baseline patient characteristics and laboratory data were also incorporated to enhance model performance. The model’s predictive ability was evaluated using the coefficient of determination (R²) and mean squared error (MSE).</p> Results <p>A total of 1065 images from 352 patients were included. The initial model achieved an R² of 0.55 and an MSE of 1004.07. Subgroup analysis revealed that the right intercostal view yielded the best performance (R²=0.74, MSE = 637.99). After incorporating patient characteristics and laboratory data, the model’s performance improved significantly (R²=0.90, MSE = 245.79).</p> Conclusion <p>The AI-assisted model showed promise for accessible and non-invasive assessment of hepatic steatosis, particularly when using the right intercostal view and supplemental clinical data. Further validation is warranted to improve its accuracy and generalizability.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Quantitative Ultrasound Assessment of Liver Fat Using Deep Learning and Clinical Data Integration

  • 期刊论文

  • 发表日期：

    2025年11月7日

查看全文
  • Jirakorn Jamrasnarodom,
  • Terapap Apiparakoon,
  • Sanparith Marukatat,
  • Oracha Chaichuen,
  • Sasima Sukchareon,
  • Roongruedee Chaiteerakij

摘要

Purpose

The increasing prevalence of Metabolic Dysfunction-Associated Steatosis Liver Disease (MASLD) highlights the need for effective assessment tools, particularly for the quantitative evaluation of hepatic steatosis. Given the limited availability of transient elastography (TE), especially in resource-limited settings, we aimed to develop an Artificial Intelligence (AI) model to quantify hepatic steatosis using conventional ultrasound, which is widely available in most healthcare facilities.

Methods

Liver ultrasonographic images and Controlled Attenuation Parameter (CAP) scores obtained from TE were collected from patients between 2017 and 2023. A predictive model was developed by integrating YOLOv8 for image classification with Principal Component Analysis and Lasso regression to estimate CAP scores from the ultrasonographic images. The dataset was randomly divided into training (80%), validation (10%), and test (10%) sets. Baseline patient characteristics and laboratory data were also incorporated to enhance model performance. The model’s predictive ability was evaluated using the coefficient of determination (R²) and mean squared error (MSE).

Results

A total of 1065 images from 352 patients were included. The initial model achieved an R² of 0.55 and an MSE of 1004.07. Subgroup analysis revealed that the right intercostal view yielded the best performance (R²=0.74, MSE = 637.99). After incorporating patient characteristics and laboratory data, the model’s performance improved significantly (R²=0.90, MSE = 245.79).

Conclusion

The AI-assisted model showed promise for accessible and non-invasive assessment of hepatic steatosis, particularly when using the right intercostal view and supplemental clinical data. Further validation is warranted to improve its accuracy and generalizability.